510(k) Report

510(k) · Cleared

Cleared

Acumatch 12/14 C-Series Cemented Femoral Stems (Size 1-6), Acumatch 12/14 L-Series Cemented Femoral Stems (Size 1-5)

K052787510(k) SpecialCleared Dec 27, 200585-day reviewClass II21 CFR 888.3353

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Exactech, Inc. · LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented

Cleared on Dec 27, 2005 as substantially equivalent to K023646 (Exactech, Inc., 2002) and 2 other predicates after an 85-day review. Its family tree reaches back 2 generations to 1996. 2 later devices descend from it.

Decided
Dec 27, 2005
Review
85 days
Class
Class II
Product code
LZO
Recalls
None
Predicates
3

Its longest line of descent runs back 2 generations to K961304 (1996). 4 ancestors in all. 2 later devices descend from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2002: 1 other ancestor2001: 1 other ancestor2008: 1 descendant cleared2009: 1 descendant clearedK961304 · Aura Hip System Cemented Femoral Stem/Cemented Long Femoral Stem · Exactech, Inc. · 1996K001335 · Acumatch L-Series Cemented Femoral Stem, Model L-Series Cemented · Exactech, Inc. · 20001995200020052010201520202025
Other ancestors, by generationDescendants, by generation 1 generation back: 2 other ancestors 1 generation forward: 1 descendant2 generations forward: 1 descendant K001335 · Acumatch L-Series Cemented Femoral Stem, Model L-Series Cemented · Exactech, Inc. · 2000K961304 · Aura Hip System Cemented Femoral Stem/Cemented Long Femoral Stem · Exactech, Inc. · 19960
  1. Root · 2 generations backK961304 Aura Hip System Cemented Femoral Stem/Cemented Long Femoral StemExactech, Inc. · 1996
  2. 1 generation backK001335 Acumatch L-Series Cemented Femoral Stem, Model L-Series CementedExactech, Inc. · 2000
  3. This deviceK052787 Acumatch 12/14 C-Series Cemented Femoral Stems (Size 1-6), Acumatch…Exactech, Inc. · 2005
  4. Descendant · cites it directly · 1 of its ownK083392 Novation 12/14 Cemented Femoral StemsExactech, Inc. · 2008 · Recalled
  5. Descendant · 2 generations on · 0 of its ownK090764 Novation CFS Press-Fit and Cemented StemsExactech, Inc. · 2009

Most influential descendants

Showing 2 of 2 · See all
  • K083392Novation 12/14 Cemented Femoral StemsExactech, Inc. · 2008 · cites it directly1descendant
  • K090764Novation CFS Press-Fit and Cemented StemsExactech, Inc. · 2009 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K961304Aura Hip System Cemented Femoral Stem/Cemented Long Femoral StemExactech, Inc.1996—
−1K001335Acumatch L-Series Cemented Femoral Stem, Model L-Series CementedExactech, Inc.2000—
0 (this device)K052787Acumatch 12/14 C-Series Cemented Femoral Stems (Size 1-6), Acumatch 12/14…Exactech, Inc.2005—
+1K083392Novation 12/14 Cemented Femoral StemsExactech, Inc.20081
+2K090764Novation CFS Press-Fit and Cemented StemsExactech, Inc.2009—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
200210

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200810
200910
FIG. 1 — Lineage of K052787, 1996–2009Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZO? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZO device

  1. #1 K192827 Quadra-Pscore 19.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K023646Exatech Acumatch Integrated Hip System C-Series Cemented Femoral Stem
Summary page 2
…r Model Name Manufacturer Number K023646 AcuMatch 12/14 C-Series Cemented Femoral Stems (Size 1-6)…
Exactech, Inc.2002—
*K001335Acumatch L-Series Cemented Femoral Stem, Model L-Series Cemented
Summary page 2
…AcuMatch 12/14 C-Series Cemented Femoral Stems (Size 1-6) Exactech, Inc. K001335 AcuMatch 12/14 L-Series Cemented Femoral Stems (Size 2-5) K011218 AcuMatch…
Exactech, Inc.2000—
*K011218Acumatch L-Series Cemented Femoral Stem, Model Size 1
Summary page 2
…Exactech, Inc. K001335 AcuMatch 12/14 L-Series Cemented Femoral Stems (Size 2-5) K011218 AcuMatch 12/14 L-Series Cemented Femoral Stems (Size I) INDICATIONS…
Exactech, Inc.2001—

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K083392Novation 12/14 Cemented Femoral StemsExactech, Inc.20081

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 9 years and passes through 1 company; a new generation was cleared every 5.6 years on median.
  • None of the 4 ancestors has a recall.
  • Of its descendants, K083392 (Exactech, Inc., 2008) has gone furthest, with 1 descendant of its own.

How does its category compare?

All LZO devices

LZO Prosthesis, Hip, Semi-Constrained, Metal/Ceramic/Polymer, Cemented Or Non-Porous, Uncemented: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LZO

14in 2025

2007: 92008: 112009: 72010: 152011: 132012: 142013: 262014: 132015: 122016: 102017: 162018: 182019: 282020: 182021: 122022: 112023: 102024: 112025: 142026 (partial year): 9
2007high 28 (2019) · low 7 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZO

119in 2025

2007: 87 days median2008: 63 days median2009: 83 days median2010: 78 days median2011: 87 days median2012: 98 days median2013: 100 days median2014: 85 days median2015: 115 days median2016: 177 days median2017: 257 days median2018: 163 days median2019: 109 days median2020: 112 days median2021: 170 days median2022: 279 days median2023: 122 days median2024: 111 days median2025: 119 days median2026 (partial year): 102 days median
2007high 279 (2022) · low 63 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZO

1in 2025

2007: 22008: 132009: 422011: 102012: 142014: 12015: 12016: 92017: 52018: 22019: 42020: 32022: 42023: 22024: 12025: 1
2007high 42 (2009) · low 0 (2010)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LZO

3,244in 2025

2007: 1382008: 1252009: 1892010: 3942011: 5442012: 9632013: 1,3702014: 1,4772015: 1,3482016: 1,7282017: 2,1652018: 3,1332019: 3,0662020: 1,9632021: 2,1992022: 1,9852023: 2,0662024: 2,5862025: 3,244
2007high 3,244 (2025) · low 125 (2008)2025

MAUDE reports naming product code LZO, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20079872138
2008116313125
200978342189
201015780394
2011138710544
2012149814963
20132610001,370
2014138511,477
20151211511,348
20161017791,728
20171625752,165
20181816323,133
20192810943,066
20201811231,963
20211217002,199
20221127941,985
20231012222,066
20241111112,586
20251411913,244
202691020—

What is it indicated for?

All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing…

Read the full statement (142 words)

All Exactech Hip Systems are indicated for use in skeletally mature individuals undergoing primary surgery for hip replacement due to osteoarthritis, rheumatoid arthritis, osteonecrosis, post-traumatic degenerative problems of the hip, and for treatment of proximal femoral fractures where prosthetic replacement is determined by the surgeon as the preferred treatment. Components of Exactech Hip Systems are also potentially indicated for ankylosing spondylitis, congenital hip dysplasia, revision of failed previous reconstructions where sufficient bone stock is present, and to restore mobility resulting from previous fusion.

* Cemented femoral stems and cemented acetabular cups are intended for cemented fixation only.

* Press-fit femoral stems and acetabular cups are intended for press-fit fixation. Press-fit components without hydroxyapatite (HA) coating may also be used with bone cement at the discretion of the surgeon.

* Fernoral heads and endoprostheses are intended for use in cemented and press-fit applications.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K052787: Acumatch 12/14 C-Series Cemented Femoral Stems (Size 1-6), Acumatch 12/14 L-Series Cemented Femoral Stems (Size 1-5).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K052787

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026